News
The US Centers and Disease Control and Prevention is considering recommending annual Covid-19 shots to those who are older or ...
Less than a quarter of adults and around 13% of children have gotten a COVID-19 vaccination this past season, CDC data shows, ...
Concern is growing among public health experts that anti-vaccine sentiments within federal and state governments may derail ...
The CDC's vaccine committee will convene for a two-day meeting this week to consider recommendations on vaccines, including the COVID-19 vaccine for 2025-2026.
Public health experts say the anti-vaccine views fronted by the HHS secretary are wrong and undermine trust in science. But a ...
As in previous studies, the SHIELD study found health care workers who received the Novavax vaccine reported significantly ...
Officials at the Department of Health and Human Services have struggled to find records belonging to Dr. Tom Shimabukuro, the director of the CDC’s Immunization Safety Office.
The COVID-19 vaccine continues to save lives, proving the vaccination strategy paid off and was a worthwhile national ...
Five years ago, volunteers rolled up their sleeves in the first clinical trial of a vaccine against COVID-19, as the new ...
Trial for a suit by two fired 'General Hospital' crew has been delayed amid settlement efforts. Plaintiffs say they were axed ...
FRIDAY, April 4, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has delayed the full approval of Novavax’s COVID-19 vaccine. The decision had been expected by April 1, but the ...
Novavax (NVAX) announced preliminary results from the SHIELD-Utah study that showed Novavax’s COVID-19 Vaccine, Adjuvanted 2024-2025 Formula ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results